4.7 Review

The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors

Journal

ADVANCED DRUG DELIVERY REVIEWS
Volume 53, Issue 3, Pages 285-305

Publisher

ELSEVIER
DOI: 10.1016/S0169-409X(01)00233-2

Keywords

Liposomes; hyperthermia; doxorubicin; FaDu tumors; lysolipid

Funding

  1. NCI NIH HHS [CA 40355, CA 87630, CA 42745] Funding Source: Medline
  2. NIGMS NIH HHS [GM 40162] Funding Source: Medline

Ask authors/readers for more resources

Our laboratories have been working together in close collaboration for over 10 years concerning the design and performance of lipid-based drug delivery systems. Over the past 3 years we have conceived of, developed, and tested pre-clinically, a new liposome-based temperature-sensitive drug delivery system for the treatment of solid tumors. This work is reported in a series of four publications: 'J. Liposome Res. 9 (1999) 491; Cancer Res. Adv. Brief 60(5) (2000) 1197; Cancer Res. 6(9) (2000) 748; and Cancer Res. 60 (2000) 6950'. Following a brief introduction concerning the motivations behind the work, this article will review these studies, including some of our earlier work that led to these ideas, and will present the rational design of the new liposome formulation from a materials engineering perspective. (C) 2001 Published by Elsevier Science B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available